Aaron Polliack
Impact in
- Genetics top 0.1%
- Chronic Lymphocytic Leukemia Research
- Pathology and Forensic Medicine top 0.1%
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 202
- Chronic Lymphocytic Leukemia Research 177
-
- Lymphoma Diagnosis and Treatment 147
- Co-authors
- Tamar Tadmor (61 shared papers)Étienne de Harven (8 shared papers)Yossi Cohen (17 shared papers)I.S. Levij (14 shared papers)Nina Lampen (8 shared papers)Andrea Gallamini (5 shared papers)Hannah Ben‐Bassat (7 shared papers)Yair Herishanu (35 shared papers)
- Journals
- European Journal Of Haematology (22 papers)Blood (21 papers)British Journal of Haematology (15 papers)Hematological Oncology (15 papers)American Journal of Hematology (14 papers)
- Partner nations
- IsraelUnited StatesItaly
In The Last Decade
Aaron Polliack
413 papers receiving 11.0k citations
Aaron Polliack's Hit Papers
Peers
Comparison fields: 5 of 150
- Genetics 4.1k
- Pathology and Forensic Medicine 4.7k
- Hematology 1.9k
- Immunology 2.5k
- Oncology 2.5k
Countries citing papers authored by Aaron Polliack
This map shows the geographic impact of Aaron Polliack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron Polliack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron Polliack more than expected).
Fields of papers citing papers by Aaron Polliack
This network shows the impact of papers produced by Aaron Polliack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron Polliack. The network helps show where Aaron Polliack may publish in the future.
Co-authors
The 25 scholars most cited alongside Aaron Polliack, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 429 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A Prognostic Score for Advanced Hodgkin's Disease Hit paper breakdown → | 1998 | 1403 |
| 2 | Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia Hit paper breakdown → | 2015 | 1291 |
| 3 | 1976 | 358 | |
| 4 | 1973 | 282 | |
| 5 | 2016 | 199 | |
| 6 | 2001 | 190 | |
| 7 | 1979 | 154 | |
| 8 | 2001 | 151 | |
| 9 | 2006 | 140 | |
| 10 | 2005 | 138 | |
| 11 | 1996 | 134 | |
| 12 | 2012 | 118 | |
| 13 | 2010 | 115 | |
| 14 | 2009 | 111 | |
| 15 | 2013 | 99 | |
| 16 | 2000 | 98 | |
| 17 | 2007 | 98 | |
| 18 | 1996 | 93 | |
| 19 | 2021 | 92 | |
| 20 | 2009 | 89 |
About Aaron Polliack
Aaron Polliack is a scholar working on Genetics, Pathology and Forensic Medicine, Hematology, Immunology and Oncology, having authored 429 papers that have together received 11.9k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (177 papers), Lymphoma Diagnosis and Treatment (147 papers), Immunodeficiency and Autoimmune Disorders (47 papers), Acute Lymphoblastic Leukemia research (40 papers), Viral-associated cancers and disorders (33 papers), Acute Myeloid Leukemia Research (31 papers), Glycosylation and Glycoproteins Research (22 papers) and Monoclonal and Polyclonal Antibodies Research (19 papers). The work is most often cited by research in Genetics (4.1k citations), Pathology and Forensic Medicine (4.7k citations), Hematology (1.9k citations), Immunology (2.5k citations) and Oncology (2.5k citations). Aaron Polliack has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Tamar Tadmor, Étienne de Harven, Yossi Cohen, I.S. Levij, Nina Lampen, Andrea Gallamini, Hannah Ben‐Bassat, Yair Herishanu, Anat Gafter‐Gvili and Ariel Aviv. Their work appears in journals such as European Journal Of Haematology, Blood, British Journal of Haematology, Hematological Oncology and American Journal of Hematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.